These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3925875)

  • 1. Comparative in vitro activities of cefpiramide and apalcillin individually and in combination.
    Allan JD; Eliopoulos GM; Ferraro MJ; Moellering RC
    Antimicrob Agents Chemother; 1985 May; 27(5):782-90. PubMed ID: 3925875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative in vitro activities of cefpiramide and apalcillin against anaerobic bacteria.
    Wexler H; Carter WT; Harris B; Finegold SM
    Antimicrob Agents Chemother; 1984 Feb; 25(2):162-4. PubMed ID: 6712200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of apalcillin compared with that of other new penicillins and anti-Pseudomonas cephalosporins.
    Neu HC; Labthavikul P
    Antimicrob Agents Chemother; 1982 Jun; 21(6):906-11. PubMed ID: 6981375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in vitro activities of apalcillin and piperacillin against gram-negative bacilli.
    Fass RJ; Helsel VL
    Antimicrob Agents Chemother; 1984 Nov; 26(5):660-4. PubMed ID: 6440476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apalcillin [PC-904]: spectrum of activity and beta-lactamase hydrolysis/inhibition.
    Barry AL; Jones RN; Thornsberry C
    Diagn Microbiol Infect Dis; 1985 Jan; 3(1):7-17. PubMed ID: 3871382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of apalcillin compared with those of piperacillin and carbenicillin against 6,797 bacterial isolates from four separate medical centers.
    Barry AL; Jones RN; Ayers LW; Gavan TL; Gerlach EH; Sommers HM
    Antimicrob Agents Chemother; 1984 May; 25(5):669-71. PubMed ID: 6732234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro antibacterial activities of cefpiramide and other broad-spectrum antibiotics against 440 clinical isolates in China.
    Wang H; Yu Y; Xie X; Wang C; Zhang Y; Yuan Y; Zhang X; Liu J; Wang P; Chen M
    J Infect Chemother; 2000 Jun; 6(2):81-5. PubMed ID: 11810540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antibacterial activity of cefpiramide.
    Pfaller MA; Niles AC; Murray PR
    Antimicrob Agents Chemother; 1984 Mar; 25(3):368-72. PubMed ID: 6426381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in vitro activity and beta-lactamase stability of cefpiramide compared with other beta-lactam antibiotics.
    Neu HC; Chin NX
    Diagn Microbiol Infect Dis; 1985 Nov; 3(6):479-88. PubMed ID: 3877607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro activity of cefpiramide, a new parenteral cephalosporin.
    Quentin C; Noury P; Titonel M
    Eur J Clin Microbiol Infect Dis; 1988 Aug; 7(4):544-9. PubMed ID: 3141169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of U-63196E, a new cephalosporin, against clinical bacterial isolates.
    Eliopoulos GM; Gardella A; DeGirolami P; Moellering RC
    Antimicrob Agents Chemother; 1984 Apr; 25(4):401-4. PubMed ID: 6610385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A microbiological evaluation of apalcillin.
    Wiedemann B; Seeberg A
    Infection; 1983; 11(6):340-4. PubMed ID: 6421745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of Eikenella corrodens to penicillin, apalcillin, and twelve new cephalosporins.
    Goldstein EJ; Citron DM
    Antimicrob Agents Chemother; 1984 Dec; 26(6):947-8. PubMed ID: 6395802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of apalcillin alone and in combination with four aminoglycoside antibiotics against Pseudomonas aeruginosa.
    Höffler U
    Chemotherapy; 1986; 32(3):255-9. PubMed ID: 3086049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
    Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental efficacy of apalcillin and cefpiramide compared with that of six other antipseudomonal agents in Pseudomonas aeruginosa burn infections.
    Fu KP; Vince T; Hung PP; Gregory JF
    Drugs Exp Clin Res; 1986; 12(4):303-6. PubMed ID: 3720518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental efficacy and pharmacokinetic properties of cefpiramide, a new cephalosporin.
    Fu KP; Vince T; McCloud S; Gregory FJ; Chiang ST; Hung PP
    Drugs Exp Clin Res; 1985; 11(11):787-91. PubMed ID: 3939215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefpiramide: comparative in-vitro activity and beta-lactamase stability.
    Barry AL; Jones RN; Thornsberry C; Fuchs PC; Ayers LW; Gavan TL; Gerlach EH; Sommers HM
    J Antimicrob Chemother; 1985 Sep; 16(3):315-25. PubMed ID: 3877041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bacteriostatic activity of apalcillin on Gram-negative bacilli and strict anaerobic bacteria. Multicenter study].
    Quentin C; Auzerie J; Bebear C; Acar JF; Kitzis MD; Avril JL; Moillo-Batt A; Shacoori Z; Bergogne-Berezin E; Joly-Guillou ML
    Pathol Biol (Paris); 1984 May; 32(5):301-6. PubMed ID: 6429608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro inhibitory and bactericidal activity of cefpiramide and seven antipseudomonal agents against Pseudomonas aeruginosa.
    Pfaller M; Bale M; Preston T; Howard W; Koontz F
    Diagn Microbiol Infect Dis; 1986 May; 5(1):17-23. PubMed ID: 3086026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.